Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

435 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effect of the weak androgen oxandrolone on psychological and behavioral characteristics in growth hormone-treated girls with Turner syndrome.
Menke LA, Sas TC, Visser M, Kreukels BP, Stijnen T, Zandwijken GR, de Muinck Keizer-Schrama SM, Otten BJ, Wit JM, Cohen-Kettenis PT. Menke LA, et al. Among authors: stijnen t. Horm Behav. 2010 Mar;57(3):297-305. doi: 10.1016/j.yhbeh.2009.12.011. Epub 2010 Jan 4. Horm Behav. 2010. PMID: 20053349 Clinical Trial.
Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial.
Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, Jansen M, Otten BJ, Hoorweg-Nijman JJ, Vulsma T, Massa GG, Rouwe CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SL. Sas TC, et al. Among authors: stijnen t. J Clin Endocrinol Metab. 1999 Dec;84(12):4607-12. doi: 10.1210/jcem.84.12.6241. J Clin Endocrinol Metab. 1999. PMID: 10599727 Clinical Trial.
Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.
van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, Sas TC, Jansen M, Otten BJ, Hoorweg-Nijman JJ, Vulsma T, Stokvis-Brantsma WH, Rouwé CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SL. van Pareren YK, et al. Among authors: stijnen t. J Clin Endocrinol Metab. 2003 Mar;88(3):1119-25. doi: 10.1210/jc.2002-021171. J Clin Endocrinol Metab. 2003. PMID: 12629094 Free article. Clinical Trial.
Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
van Teunenbroek A, de Muinck Keizer-Schrama SM, Stijnen T, Jansen M, Otten BJ, Delemarre-van de Waal HA, Vulsma T, Wit JM, Rouwé CW, Reeser HM, Gosen JJ, Rongen-Westerlaken C, Drop SL. van Teunenbroek A, et al. Among authors: stijnen t. J Clin Endocrinol Metab. 1996 Nov;81(11):4013-21. doi: 10.1210/jcem.81.11.8923853. J Clin Endocrinol Metab. 1996. PMID: 8923853 Clinical Trial.
Growth response and levels of growth factors after two years growth hormone treatment are similar for a once and twice daily injection regimen in girls with Turner syndrome. (Dutch Working Group on Growth Hormone).
van Teunenbroek A, de Muinck Keizer-Schrama S, Stijnen T, Waelkens J, Wit JM, Vulsma T, Gerver WJ, Reeser H, Delemarre-van de Waal H, Jansen M, Drop S. van Teunenbroek A, et al. Among authors: stijnen t. Clin Endocrinol (Oxf). 1997 Apr;46(4):451-9. doi: 10.1046/j.1365-2265.1997.1610972.x. Clin Endocrinol (Oxf). 1997. PMID: 9196608 Clinical Trial.
Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Dutch Advisory Group on Growth Hormone.
Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, van Teunenbroek A, Hokken-Koelega AC, Waelkens JJ, Massa GG, Vulsma T, Gerver WJ, Reeser HM, Delemarre-van de Waal HE, Jansen M, Drop SL. Sas TC, et al. Among authors: stijnen t. Arch Dis Child. 1999 Jan;80(1):36-41. doi: 10.1136/adc.80.1.36. Arch Dis Child. 1999. PMID: 10325756 Free PMC article. Clinical Trial.
435 results